Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etifoxine vs Lorazepam on Vigilance in Elderly
NCT02147548Phase 3Completed
- Sponsor
- Biocodex
- Start
- Dec 2013
- Primary completion
- Oct 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etifoxine in anxiety disorder, sponsored by Biocodex. Started Dec 2013; status: completed.
02
Drugs
etifoxine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT02147548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147548.